Managing Burnout in the Pharmacy
Pharmacy Times
SEPTEMBER 25, 2023
Physical symptoms of burnout can include headaches, digestive problems, sleep disturbances, and increased susceptibility to illnesses due to a weakened immune system.
Sat.Sep 23, 2023 - Fri.Sep 29, 2023
167 
CVS Pharmacists, Staff in Kansas City Stage Walkout Over Working Conditions
Drug Topics
SEPTEMBER 26, 2023
Pharmacists at nearly 2 dozen CVS pharmacy locations called out sick Thursday and Friday to protest recent corporate decisions they say put patients at risk of serious harm.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Pharmacies and Labs Must Work Together to Accelerate Test and Treat Opportunities, Enhance Patient Care Equity, Improve Health Outcomes
Pharmacy Times
SEPTEMBER 27, 2023
Working together, pharmacies and labs can answer the call to align and back legislation that supports pharmacists as providers, help patients gain greater access to affordable care, and reap the benefits of improved health outcomes while growing business revenue.
Elderly exclusion: Clinical trials still fall short enrolling older adults
PharmaVoice
SEPTEMBER 25, 2023
Despite high rates of disease in older populations, systemic issues are keeping them out of research studies.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
WHO recommends dropping component of many flu vaccines
STAT
SEPTEMBER 29, 2023
The World Health Organization has recommended dropping a component of many flu vaccines because the viruses it protects against appear to have been driven into extinction in the Covid-19 pandemic. A family of viruses known as influenza B/Yamagata has not been seen since March 2020, when flu circulation worldwide declined to very low levels in the face of the onslaught of Covid and the protections people took to avoid contracting it.
Pharmacists Work to Sustain Care in Health Care Deserts
Drug Topics
SEPTEMBER 29, 2023
When rural areas lose hospitals and primary care clinics, residents must turn to pharmacies to receive the care they need.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Do humans have a place in pharma’s AI future?
PharmaVoice
SEPTEMBER 26, 2023
From COTA’s large datasets and AI model assistants to a company guiding patients through cancer care, AI can help — but it’s a long way from human-free.
Did the government get a bad deal on the Covid-19 boosters?
STAT
SEPTEMBER 28, 2023
WASHINGTON — After Pfizer and Moderna hiked the prices of their Covid-19 vaccines this year, the federal government will now pay nearly three times more than it did previously for each dose. And it’s paying more than countries that did far less to support vaccine development. Health and Human Services Secretary Xavier Becerra glossed over the dramatic increase in the amount the government is paying for vaccines in a public appearance last week, when he got vaccinated at a CVS pharm
Breaking: Class Action Lawsuit Filed Against CVS Health, Caremark, Aetna to Recoup DIR Fees
Drug Topics
SEPTEMBER 27, 2023
The class action lawsuit against CVS Health, Caremark, and Aetna was announced earlier today.
Clinical Overview: Lecanemab Use, Coverage for Alzheimer Disease
Pharmacy Times
SEPTEMBER 26, 2023
In clinical trials, lecanemab showed a reduction of amyloid beta plaque in patients with Alzheimer disease.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Inside Bavarian Nordic’s late-stage stumbles — and its drive to become a vaccine giant
PharmaVoice
SEPTEMBER 27, 2023
Despite recent phase 3 setbacks in RSV and COVID-19, CEO Paul Chaplin sees a promising path forward in the travel vaccine market for the Dutch biotech.
Exodus of life scientists from academia reaches historic levels, new data show
STAT
SEPTEMBER 28, 2023
New data released Thursday by the National Science Foundation show the exodus of young life scientists from the Ivory Tower to industry has reached the highest level in nearly three decades, deepening concerns about the future of academic science in the U.S. Among newly minted life science Ph.D.s in 2022 who had firm next steps, roughly 53% planned to pursue postdoctoral research, a temporary period of additional training that is virtually a requirement for those hoping to land a faculty job.
CVS Implements Measures to Improve Working Conditions After More Kansas City Pharmacists Stage Walkouts
Drug Topics
SEPTEMBER 29, 2023
After several walkouts protesting poor working conditions, company executives and protest organizers came to an agreement that includes more hours for technicians and vaccinations being reduced to a manageable volume.
New Vaccine Significantly Improved Lifespan of Patients With Multiple Myeloma in Phase 1 Trial
Pharmacy Times
SEPTEMBER 26, 2023
Most patients had improved clinical response within 90 days of receiving the dendritic cell vaccine and ASCT.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pfizer CEO Albert Bourla led Big Pharma bonus payouts over 5 years — but he’s no Elon Musk
PharmaVoice
SEPTEMBER 28, 2023
A recent report showed how pharma’s bonuses pale in comparison to other industries, but several execs still rake in hefty packages.
STAT+: The Ozempic revolution is rooted in the work of Svetlana Mojsov, yet she’s been edged out of the story
STAT
SEPTEMBER 27, 2023
On a mild May day in 1993, about 60 scientists and doctors gathered on a lawn in Copenhagen to commemorate the first International Symposium on GLP-1, the hormone that decades later would become the basis for highly effective diabetes and obesity drugs like Ozempic and Wegovy. The meeting was a scientific showcase of all the leading experts in the nascent field.
Independent Pharmacies Say They Can Help Patients Impacted by Chain Store Closures, NCPA Survey Finds
Drug Topics
SEPTEMBER 29, 2023
A new poll from the organization surveyed 10000 independent community pharmacy owners on current worries in the industry and how they are being impacted by the ongoing national drug shortage.
New Vaccines Enable Pharmacies to Become Immunization Destinations
Pharmacy Times
SEPTEMBER 25, 2023
For community pharmacists, cooler temperatures, school buses on the roads and Friday night football are not just signs of a changing season – they are indicators that patients will soon be seeking vaccinations for the 2023-2024 respiratory illness season.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
How pharma marketers can reclaim the drug pricing narrative
PharmaVoice
SEPTEMBER 28, 2023
As Medicare negotiations heat up, it’s more important than ever for pharma companies to communicate their value. Here’s how.
Gene therapy death was caused by an unknown risk of the virus used, study suggests
STAT
SEPTEMBER 27, 2023
Last October, a 27-year-old man with Duchenne muscular dystrophy died after receiving a CRISPR-based treatment custom built to treat his particular genetic mutation. Results of a detailed investigation released on Wednesday suggest that the patient, Terry Horgan, likely died of a previously undocumented adverse effect of the virus used to deliver the CRISPR machinery to his cells.
Glycemic Control in Patients With Type 1 Diabetes Worse Around Holidays, Winter Months
Drug Topics
SEPTEMBER 28, 2023
A new study from Dartmouth College found that patients maintained healthier blood sugar levels from April to September.
Incidence of Type 2 Diabetes Increased Significantly Following COVID-19 Pandemic
Pharmacy Times
SEPTEMBER 29, 2023
Investigators also found that rates of type 1 diabetes have been on the rise since 2016.
3 recent FDA adcomm rejections — and why they matter
PharmaVoice
SEPTEMBER 29, 2023
Decisions that could spell doom for drugs in development and already on the shelves.
Flu, Covid vaccination rates decline, as U.S. health officials make new push for inoculations
STAT
SEPTEMBER 28, 2023
Vaccination rates against flu and Covid-19 have declined since earlier in the pandemic and a new survey suggests significant portions of the U.S. population intend to forgo these vaccines this fall. The survey, conducted by the National Foundation for Infectious Diseases, suggests only about one in five Americans worry that they or someone in their family will contract influenza, Covid, or RSV — respiratory syncytial virus.
More Women Are Using Cannabis to Manage Menopause Symptoms
Drug Topics
SEPTEMBER 28, 2023
A new study found that the most common symptoms that cannabis was used to treat were chronic pain, anxiety, sleep problems, and stress.
Study Finds Individuals Prefer PrEP Over Other HIV Prevention Methods
Pharmacy Times
SEPTEMBER 29, 2023
Individuals taking HIV prevention prefer the PrEP oral daily dose compared to new treatment methods.
The PharmaVoice 100: Standout execs
PharmaVoice
SEPTEMBER 25, 2023
Leaders who’ve created unique strategies for thriving amid the heavy headwinds facing the industry.
Rollout of Covid vaccines is bumpy, but not unexpected, experts say
STAT
SEPTEMBER 26, 2023
The latest rollout of Covid-19 vaccines has been messy, with people facing more challenges getting one of the updated shots than they may have experienced since the frantic start of the very first vaccination campaign in late 2020 and the first half of 2021. The issues have come as a surprise to people whose appointments have been canceled for lack of vaccine doses, who couldn’t get an appointment at their nearest pharmacy, or who learned with dismay that the place where they got previous
Long COVID Associated With Hormonal, Immune Differences
Drug Topics
SEPTEMBER 25, 2023
A new study from Yale School of Medicine and Icahn School of Medicine at Mount Sinai found that patients with long COVID had increased antibodies that help fight different viruses and lower levels of cortisol.
Lead Investigator Provides Insight Into FDA Approval of Momelotinib for Myelofibrosis
Pharmacy Times
SEPTEMBER 29, 2023
Ruben A. Mesa, MD, FACP, discusses the results of the SIMPLIFY-1 and MOMENTUM trials and how the data led to the approval of momelotinib to treat intermediate or high-risk myelofibrosis in adult patients with anemia.
For Astellas’ CMO, accelerating innovation means working at the edge of your comfort zone
PharmaVoice
SEPTEMBER 25, 2023
Scientific discovery through new, breakthrough modalities is essential to solve current and future global health challenges – but the path is not easy nor well-defined.
Black people are more likely to be physically restrained in emergency rooms, study finds
STAT
SEPTEMBER 25, 2023
In the chaotic environment of an emergency room, hospital staffers sometimes face the question of whether to use physical restraints when a patient is experiencing a behavioral crisis. Using restraints is meant to be a last resort in the face of a patient’s agitation in order to keep health care workers and others around them safe. But restraints can also lead to severe adverse outcomes for patients, including physical and psychological trauma.
Opioid Use Disorder Medication Initiation After ED Visits for Overdose Remains Low
Drug Topics
SEPTEMBER 27, 2023
A study from the University of Michigan found that only 1 in 6 emergency department visits for an opioid overdose in the United States result in a prescription for buprenorphine, methadone, or extended-release naltrexone.
Let's personalize your content